Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

NFX

Nuformix (NFX)

Nuformix Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:NFX
DateHeureSourceTitreSymboleSociété
19/03/202415h39RNS Regulatory NewsNuformix PLC Result of AGMLSE:NFXNuformix Plc
01/03/202411h31Alliance NewsAlliance NewsIN BRIEF: Nuformix announces subscription to raise GBP150,000LSE:NFXNuformix Plc
01/03/202408h00RNS Regulatory NewsNuformix PLC Subscription to raise £150,000LSE:NFXNuformix Plc
15/01/202412h30UK RegulatoryNuformix PLC Posting of Annual Report and Notice of AGMLSE:NFXNuformix Plc
03/01/202411h16Alliance NewsAlliance NewsIN BRIEF: Nuformix narrows annual loss as develops drug assetsLSE:NFXNuformix Plc
03/01/202408h00UK RegulatoryNuformix PLC Results for the period ended 30 September 2023LSE:NFXNuformix Plc
18/12/202308h00UK RegulatoryNuformix PLC NXP001 UpdateLSE:NFXNuformix Plc
23/10/202313h38Alliance NewsAlliance NewsNuformix gets patent in Japan for pulmonary fibrosis treatment NXP002LSE:NFXNuformix Plc
23/10/202308h04UK RegulatoryNuformix PLC Notice of Allowance of NXP002 Patent in JapanLSE:NFXNuformix Plc
18/09/202311h20Alliance NewsAlliance NewsIN BRIEF: Nuformix to receive milestone payments from Oxilio pactLSE:NFXNuformix Plc
24/08/202314h22UK RegulatoryNuformix PLC Result of Annual General MeetingLSE:NFXNuformix Plc
31/07/202315h00UK RegulatoryNuformix PLC Notice of AGMLSE:NFXNuformix Plc
26/07/202315h55UK RegulatoryNuformix PLC Holding(s) in CompanyLSE:NFXNuformix Plc
02/06/202308h00RNS Non-RegulatoryNuformix PLC Investor Online Q&ALSE:NFXNuformix Plc
25/05/202308h00UK RegulatoryNuformix PLC Change of AuditorLSE:NFXNuformix Plc
22/05/202313h45Alliance NewsAlliance NewsNuformix loss narrows; near-term goal to focus on NXP002 assetLSE:NFXNuformix Plc
22/05/202308h00UK RegulatoryNuformix PLC Unaudited Interim ReportLSE:NFXNuformix Plc
18/05/202315h31Alliance NewsAlliance NewsTRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effectLSE:NFXNuformix Plc
18/05/202308h00UK RegulatoryNuformix PLC NXP002 Inflammation and Duration of Action UpdateLSE:NFXNuformix Plc
17/04/202313h14Alliance NewsAlliance NewsNuformix raises GBP70,000 to fund NXP002 programmeLSE:NFXNuformix Plc
17/04/202308h00UK RegulatoryNuformix PLC Subscription to raise GBP70,000 & issue of WarrantsLSE:NFXNuformix Plc
27/03/202319h42Alliance NewsAlliance NewsTRADING UPDATES: Sabien works with Empiric; Coro sells in ItalyLSE:NFXNuformix Plc
27/03/202308h00UK RegulatoryNuformix PLC NXP002 UpdateLSE:NFXNuformix Plc
13/03/202308h00UK RegulatoryNuformix PLC Change of Accounting Reference DateLSE:NFXNuformix Plc
15/02/202313h12Alliance NewsAlliance NewsNuformix progresses NXP002 trial after acquiring human tissueLSE:NFXNuformix Plc
20/12/202208h00UK RegulatoryNuformix PLC NXP004 UpdateLSE:NFXNuformix Plc
13/12/202215h54Alliance NewsAlliance NewsNuformix interim loss virtually flat as continues work on drugsLSE:NFXNuformix Plc
13/12/202208h00UK RegulatoryNuformix PLC Half-year ReportLSE:NFXNuformix Plc
05/12/202208h00UK RegulatoryNuformix PLC Resignation of AuditorLSE:NFXNuformix Plc
04/11/202208h00RNS Non-RegulatoryNuformix PLC Investor WebinarLSE:NFXNuformix Plc
 Showing the most relevant articles for your search:LSE:NFX